The federal government announced Thursday that it will be requiring the Food and Drug Administration (FDA) to begin testing Viagra for the treatment of erectile dysfunction (ED). Under the proposed guidance of the FDA, Viagra will be made available through a mail-order pharmacy.
Viagra’s maker, Pfizer, had previously proposed the agency to start testing it as soon as possible after it announced in November that it would start testing for the treatment of ED.
The FDA has not heard from the company’s partner, Lupin Pharmaceuticals, about the plan, but Lupin says it is aware of the potential for FDA approval, and is reviewing whether it should be considered.
The company is also reviewing the safety and efficacy of Viagra, which it has been testing for several years.
Viagra, which is the world’s second-biggest prescription-drug company, is being tested for the treatment of ED and is expected to be available starting December 2023.
In its submission to the FDA, Lupin said it has not received any public comment about the company’s proposal. The agency said it had received no adverse events reported from the FDA and that the agency was aware of the potential risks for consumers.
“Consumers should be aware that the FDA’s proposed testing for the efficacy of Viagra is not approved for use in the U. S., and will be subject to public comment for approval,” Lupin wrote.
The drug’s maker, Pfizer, did not respond to a request for comment. The company is evaluating whether the FDA will approve the test, and said it has not received any positive or negative adverse events.
The FDA has also said it expects to submit a similar drug safety review into Viagra’s effectiveness for other conditions, including erectile dysfunction, in the future.
“We continue to evaluate the efficacy and safety of Viagra in men who are at high risk of adverse events from its use,” said David A. Schaffey, spokesman for Pfizer, which has been testing Viagra for several years.
Schaffey said the company is also reviewing its review of the FDA’s review of the drug’s safety and efficacy for use in treating erectile dysfunction, and also said it is reviewing the safety and efficacy of the drug in the future.
A spokesman for Pfizer said in a statement that “the FDA has not received any positive or negative side-effect reports from our patients with ED.”
The FDA has not received any negative side effects from Viagra, but it did say that it is evaluating whether it should be approved for use in the U. S. for the treatment of ED.
A spokesman for Pfizer said the company is reviewing the company’s review of the FDA’s review of the drug’s safety and efficacy.
“Pfizer’s investigation of its safety and efficacy data is ongoing, and we’re continuing to evaluate our safety and efficacy data to ensure Viagra’s efficacy and safety are not compromised by the FDA review of Viagra,” said Charles G. Lechleiter, Pfizer’s spokesman.
The company is reviewing the safety and efficacy of Viagra and other ED drugs, and said it is assessing the company’s review of its safety and efficacy data.
Pfizer is also reviewing Viagra’s side effects and safety in the U. S., and the FDA will consider whether other similar drugs, such as Cialis, may be used for the treatment of ED.
Viagra is approved for the treatment of erectile dysfunction by the FDA in 1998, and has been available since its patent in 2003.
“This review, which is based on information received from patients, is very thorough and will address some of the most serious and persistent side effects of Viagra,” said Michael E. Cummings, spokesman for the FDA’s Center for Drug Evaluation and Research.
The FDA will submit a drug safety review of Viagra’s efficacy and safety for use in the U. to make sure it is safe for use, and that the company has no indication that it can treat ED.
Cummings said the FDA has not received any positive or negative events from the drug, and that the company is reviewing its safety and efficacy data.
Viagra has been shown to cause some mild side effects. Talk to your health care provider if these do not go away within a few days. If you begin to experience more serious reactions, seek medical attention immediately.
Common side effects reported from Viagra use include:
More severe side effects include:
If you experience any of these side effects, seek medical attention immediately. These are symptoms of a severe adverse reaction to this medication that require immediate treatment.
As with all prescription medications, inform your doctor of any medical conditions you currently manage. Tell them about any and all medications, prescription drugs, and supplements you are taking before starting treatment with Viagra. Viagra can interact with bodily substances, causing potentially serious adverse reactions.
Specifically, you should inform your health care provider of any nitrate medication you are taking. Remember to mention any herbal products you use, especially St. John’s wort.
In addition, let your doctor know if you have recently had heart surgery or experience chest pain during sex. If you experience any changes in your heartbeat or chest pain during sex, contact your health care provider immediately.
Show MoreBulk Purchase PriceGet Shipping over $3Get Price & Delivery - Order now at LowerMyGap Pharmacy in QatarProduct Code: MEDFEN-IP-HOLDIPOPE. COM
Product Code : MEDFEN-IP-HOLDIPOPE.Made in: Qatar
Product nameRescale Viagra 50mg, 100mg
Manufacturer: Pfizer
Country of Origin: India
ManufacturerManufacturer address:
4250 Virginia Dr.Viagra Connect is a new erectile dysfunction treatment which does not require a prescription.
The first of its kind, Viagra Connect is a safe and discreet over-the-counter medication that can legally be bought online without a trip to your doctor.
We need to ensure that this medicine is suitable for the person it is intended for. Therefore, it should only be purchased by the person taking it.
A pharmacist may need to contact you by phone before providing the product. If they cannot reach you within 72 hours, your order may be delayed, or this item may be cancelled from your order.
Please ensure your contact details are correct before ordering this medicine.Suitable forViagra Connect is for men 18 years and older who have difficulty getting and/or keeping an erection hard enough for sex
Age RestrictionYou must be at least 18 years old to purchase this product.
Directions for use:Please read the enclosed leaflet carefully before use.
• take 1 tablet approximately one hour before sexual activity• swallow tablet whole with water• do not take more than 1 tablet a dayViagra Connect starts to work within 30-60 minutes. You may take it up to 4 hours before sexual activity.
Hazards and Cautions
Do NOT take if you:
Talk to your pharmacist or doctor before taking if you:
As with all medicines, please ensure you read the patient information leaflet before taking this item.
Please read the patient information leaflet carefully before use.Do not take if you:Do not have an erection problem. You may get an erection when taking Viagra Connect. Your erection could loss orocused force into your vision. It may get better or worse, depending on itsarity with you. If it depends on your health, you will want to use caution. See also Precription and Precautions section.Talk to your pharmacist or doctor if you are not sure:
urgavena.co.uk
Please ensure full pharmacistindication before ordering this item.You will need to complete a quick online consultation with a pharmacist who can buy you a Prescription ED medicine during your online order.You can get the prescription for $59.76.You may also use our non-prescription service to obtain prescription ED medicines.Please ensure your complete order confirm email address and email ID are correct before calling the online consultation party. It will help you get the prescription for $59.76.
There will be one per item.You will be able to order 2 prescriptions within 24 hours.The total processing time is not more than 3-4 days.You will be able to purchase the prescription ED medicine yourselfThe online consultation is held twice daily (during meal which is allowed to pass).A new study published inJAMA Psychiatryin July finds that men who are prescribed sildenafil, the generic name for Viagra, have a significantly lower likelihood of developing Alzheimer’s disease.
Sildenafil is sold under the brand name Revatio, and it’s also a drug approved by the US Food and Drug Administration (FDA) to treat pulmonary arterial hypertension and benign prostatic hyperplasia. But this new study found that Viagra users who also take sildenafil have a slightly lower risk of developing Alzheimer’s disease, but only about a quarter of the people who do.
“Although the risk for Alzheimer’s is still small, we believe that the beneficial effect of sildenafil on Alzheimer’s-related dementia is likely to be greater,” says lead author and lead author of the study, David P. Johnson, of the University of South Carolina at Chapel Hill. “These results are important because they highlight a new opportunity to explore this drug’s potential to treat Alzheimer’s disease.”
Johnson and his colleagues used data from the National Health and Nutrition Examination Survey and found that those who are prescribed sildenafil have a slightly lower risk of Alzheimer’s disease than those who don’t.
“This is an important finding, given the small number of people who are prescribed sildenafil,” says Johnson. “It suggests that sildenafil may be able to improve the quality of life for some men with Alzheimer’s who don’t.
The study, published online April 14 in the, analyzed data from the National Health and Nutrition Examination Survey, a nationally representative survey that includes the United States.
The results revealed that men who are prescribed sildenafil are less likely to develop Alzheimer’s than men who don’t take sildenafil, and that a quarter of the men who do take sildenafil were more likely to be diagnosed with Alzheimer’s.
In contrast, men who don’t take Viagra had the highest risk of developing Alzheimer’s, and those who do were also more likely to be diagnosed with Alzheimer’s, the researchers found.
The study, funded by Pfizer and the Alzheimer’s Association of America, found that Viagra users who also take sildenafil had a slightly lower risk of developing Alzheimer’s, but only about a quarter of the men who do take sildenafil were diagnosed with Alzheimer’s.
Johnson says his research shows that the findings are not as alarming as he hoped for. “I was shocked to discover that the findings are not as alarming as I had hoped for,” he says.
In fact, it may be because there are other factors to consider, he says. “Viagra is associated with increased risk of Alzheimer’s disease, which is why it has been recommended that men who are taking Viagra should take the medication for the full prescribed length of time to prevent dementia.”
“However, our results demonstrate that the association of sildenafil with Alzheimer’s disease is likely to be even more robust,” he adds.
In other words, researchers need to be very careful with the drug they are prescribing, and it is also possible that other factors could be causing this association.
Johnson says the findings are important because “we don’t know the effect of sildenafil on Alzheimer’s disease in general. It’s not a surprise to me that the results may be somewhat reassuring.”
“I would be more worried about the results from a study that is being done at a time when many other drugs are used to treat Alzheimer’s disease,” he says. “However, it may be possible to use sildenafil and other medicines to treat Alzheimer’s disease and prevent dementia from taking place.”
Johnson, who was not involved in the research, agrees that there are other factors to consider, especially for men with Alzheimer’s.
“I think it is important to acknowledge that this is a very small sample of men, and I’m very concerned about the results,” he says.
Stade de France Pharmacy